Influence of life expectancy on shared decision-making for prostate cancer screening.

ABSTRACT:

Purpose

The U.S. Preventive Services Task Force recommends that men aged 55-69 years undergo shared decision-making (SDM) regarding prostate cancer (PCa) screening, and routine screening is not recommended for older men or those with limited life expectancy. We evaluated the association between individual life expectancy and the receipt and content of SDM.

Methods

We identified male respondents aged ≥ 50 years and older without a history of PCa within the 2020 Behavioral Risk Factor Surveillance System survey. SDM was defined as whether a healthcare professional had ever discussed the advantages and/or disadvantages of a prostate-specific antigen test with the respondent. Life expectancy was estimated based on a validated index incorporating respondent age, comorbidities, an

SUBMITTER: Reed MM 

PROVIDER: S-EPMC12621089 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature